Liraglutide initiation after hospital discharge was comparable to insulin for glycemic control, with less incidence of hypoglycemia. 

How do the long-term benefits and complicating factors of bariatric surgery in type 1 diabetes patients compare to those with type 2?

Is there an ideal approach to screen and diagnose children and adolescents for prediabetes and diabetes?

I recently gave a webinar for the American College of Sports Medicine (and Technogym) that reached almost 1,200 participants in real time. You can watch the webinar, titled “The Role of Physical Activity in Type 2 Diabetes Management and Prevention,” posted on Youtube.

While it does not yet have FDA approval, researchers find novel dual SGLT-1/2 inhibitor, sotagliflozin, is efficacious and safe for patients with type 2 diabetes.

A low-calorie diet was a safe and effective treatment for individuals with newly diagnosed T2D and obesity.

Tirzepatide's dual-action may significantly impact a person's weight management and blood glucose compared to GLP-1 receptor agonists like semaglutide.

Recent trials are showing that gastrointestinal surgery may be the new cure for type 2 diabetes, but few patients have access to it.

Study shows that breastfeeding can provide diabetes inhibiting effects for over three years.

In managing type 1 diabetes, a single combined formulation of pramlintide and prandial insulin can provide multiple benefits.